Business Development Specialist - Foot & Ankle DACH
About the job
- A completed degree, for example in medical technology, industrial engineering, marketing, business administration, or a STEM field, or a comparable qualification through relevant vocational training, for example in a medical field as an operating-room or chemical-technical assistant, with substantial professional experience.
- At least 3 years of successful medical-device sales experience using a strategic sales approach; experience with implants, surgery, or operating-room technology is preferred.
- Good knowledge of Microsoft Office 365.
- Very good German and good English skills, spoken and written.
- A Class B driver's license and approximately 75% willingness to travel in the specified region.
- Own sales development and sales projects for the Foot & Ankle product area among designated DACH-region customers.
- Support field sales in acquiring new customers and servicing strategically important existing customers, including operating-room support, workshops, and mini-labs.
- Work closely with marketing management to develop and implement product-launch strategies, including commercialization and reimbursement; prepare market and competitive analyses; and plan and execute targeted marketing activities.
- Collaborate with sales, Market Access, the outpatient business, and Medical Education teams in the DACH region.
- Participate in trade events, congresses, and workshops.
- Manage relationships with key opinion leaders.
- Contribute to internal and external communications on relevant Foot & Ankle topics in coordination with marketing, sales, and other stakeholders.
- Support training for field sales.
- Experience in orthopedics or sports medicine, including arthroscopy or endoscopy.
- Experience in an international corporation with a matrix organization.
About the company
Smith+Nephew is a global medical technology company that designs and makes medical devices for orthopaedics, sports medicine, and advanced wound care. Its products help surgeons treat joints and soft tissues and support patient recovery, including knee repair systems, single-use negative pressure wound therapy devices, and other extremity orthopaedic products. These devices are used in hospitals and clinics to perform procedures and support healing, often after surgery or injury. The company differentiates itself with a broad, worldwide product portfolio and collaborations with healthcare organizations to improve care and efficiency for patients and providers. Its goal is to improve patient outcomes, streamline medical procedures, and expand access to advanced medical solutions around the world.
Company Size
10,001+
Company Stage
IPO
Headquarters
Watford, United Kingdom
Founded
1856
Get referred to Smith+Nephew
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q1 2026 revenue reached $1.5 billion, and full-year guidance stayed intact on May 6.
- New launches in 2026 include CORI XT, FLOW FLEXTEND, and ALLEVYN COMPLETE CARE.
- August 2026 H1 results showed 4.6% growth, $200 million efficiency savings, and $500 million buyback.
What critics are saying
- Reuters on August 4, 2026 cut revenue guidance to around 4% after weak U.S. knees.
- Smith+Nephew’s finance chief John Rogers exits September 30, 2026, creating leadership churn.
- A March 2026 humeral nail recall and older hip litigation expose recurring quality risk.
What makes Smith+Nephew unique
- Smith+Nephew’s CORI XT robotics spans knee, shoulder, and future hip workflows.
- Its ASC Solutions bundles facility design, financing, and clinical enablement for outpatient surgery.
- ALLEVYN, RENASYS, and LEAF create a broad wound-care platform with measurable outcomes.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- 401(k) Retirement Plan
- 401(k) Company Match
- Paid Vacation
- Paid Holidays
- Flexible Work Hours
- Parental Leave
- Fertility Treatment Support
- Family Planning Benefits
- Tuition Reimbursement